June 25, 2021
The Massachusetts federal judge who ran a probe into an attorney overbilling scandal in a settled class action with State Street Corp. slashed a fee request Friday in a separate case against Insulet Corp. after lambasting similar "false and misleading statements" from two firms seeking their cut of a $19.5 million deal.
February 09, 2018
Insulet Corp. has agreed to a $19.5 million settlement of a proposed class action alleging the medical device maker misled investors about the success of a new insulin infusion pump system it launched in 2013 and manipulated a critical performance metric to mask declining new patient growth, according to filings made Friday in Massachusetts federal court.
June 17, 2015
Insulet Corp. was hit with a proposed class action in Massachusetts federal court on Tuesday that claims the medical device maker and its executives misled investors about the success of a new insulin pump, concealing difficulties in production and converting customers to the product.